Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$41,331,331
-$551,263 QoQ
Shares Held
162,741
-5.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#490
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEIZERT CAPITAL PARTNERS, LLC holds $92,983,054 across 6 Drug Manufacturers - General names. JNJ ranks #1 (44.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
162,741 | $41,331,331 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
667,883 | $38,483,418 | |
| 3 | AMGN |
Amgen Inc
|
18,902 | $6,844,792 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
37,822 | $4,778,431 | |
| 5 | ABBV |
AbbVie Inc.
|
3,980 | $1,001,527 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,230 | $543,555 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,331,331 | 162,741 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $41,882,594 | 171,341 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $47,489,230 | 229,472 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $44,532,321 | 240,170 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $37,227,313 | 243,714 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $40,656,505 | 245,155 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $34,964,777 | 241,770 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $39,551,877 | 244,057 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $35,314,594 | 241,616 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $40,094,046 | 253,455 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $39,236,724 | 250,330 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $40,800,581 | 261,962 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $38,572,118 | 233,036 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $36,327,815 | 234,373 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $44,571,798 | 252,317 | Shares | Sole | 2023-03-28 | |
| 2022-09-30 | $41,974,861 | 256,947 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $46,602,942 | 262,537 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $45,945,991 | 259,245 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $44,952,063 | 262,770 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $43,153,930 | 267,207 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $41,204,274 | 250,117 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $37,314,681 | 227,044 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $36,113,988 | 229,470 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $36,082,854 | 242,362 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $36,083,689 | 256,586 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $36,278,556 | 276,661 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||